DexCom DXCM received a warning letter from the FDA on March 4, 2025, following inspections of its San Diego and Mesa facilities in 2024. The FDA cited deficiencies in the company’s manufacturing ...
Do: Respond within 15 business days of the original letter and be specific in that response. “It’s important to critically ...